Drugs / Bifluorid 10
last change Jan 2021 re-read 3 minutes ago

Bifluorid 10

Developed for
dentin sensitivity · hypersensitivity reaction disease
Investigated by
Cairo University

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT04485299 Oct → Dec 2020 dentin sensitivity, hypersensitivity reaction disease Cairo University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Bifluorid 10 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04485299 ↗